These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 34049576)
1. Manuka honey enhanced sensitivity of HepG2, hepatocellular carcinoma cells, for Doxorubicin and induced apoptosis through inhibition of Wnt/β-catenin and ERK1/2. Al Refaey HR; Newairy AA; Wahby MM; Albanese C; Elkewedi M; Choudhry MU; Sultan AS Biol Res; 2021 May; 54(1):16. PubMed ID: 34049576 [TBL] [Abstract][Full Text] [Related]
2. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC. Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633 [TBL] [Abstract][Full Text] [Related]
3. Adenine inhibits growth of hepatocellular carcinoma cells via AMPK-mediated S phase arrest and apoptotic cascade. Su WW; Huang JY; Chen HM; Lin JT; Kao SH Int J Med Sci; 2020; 17(5):678-684. PubMed ID: 32210718 [No Abstract] [Full Text] [Related]
4. Jujube honey induces apoptosis in human hepatocellular carcinoma HepG2 cell via DNA damage, p53 expression, and caspase activation. Cheng N; Zhao H; Chen S; He Q; Cao W J Food Biochem; 2019 Nov; 43(11):e12998. PubMed ID: 31373040 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis. Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993 [TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines. Lee TK; Lau TC; Ng IO Cancer Chemother Pharmacol; 2002 Jan; 49(1):78-86. PubMed ID: 11855756 [TBL] [Abstract][Full Text] [Related]
7. Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells. Saha SK; Yin Y; Kim K; Yang GM; Dayem AA; Choi HY; Cho SG Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498322 [TBL] [Abstract][Full Text] [Related]
8. Diosgenin potentiates the anticancer effect of doxorubicin and volasertib via regulating polo-like kinase 1 and triggering apoptosis in hepatocellular carcinoma cells. Yousef EH; El-Mesery ME; Habeeb MR; Eissa LA Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4883-4894. PubMed ID: 38165424 [TBL] [Abstract][Full Text] [Related]
9. Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients. Abdelmonsif DA; Sultan AS; El-Hadidy WF; Abdallah DM Mol Diagn Ther; 2018 Feb; 22(1):115-127. PubMed ID: 29094287 [TBL] [Abstract][Full Text] [Related]
10. Bauerenol, a triterpenoid from Indian Suregada angustifolia: Induces reactive oxygen species-mediated P38MAPK activation and apoptosis in human hepatocellular carcinoma (HepG2) cells. Sathish Kumar P; Viswanathan MBG; Venkatesan M; Balakrishna K Tumour Biol; 2017 Apr; 39(4):1010428317698387. PubMed ID: 28443465 [TBL] [Abstract][Full Text] [Related]
11. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways. Zhang H; Li JC; Luo H; Zhao L; Zhang ZD; Shen XF Phytomedicine; 2019 Jun; 59():152759. PubMed ID: 31004883 [TBL] [Abstract][Full Text] [Related]
12. Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma. Tong AW; Su D; Mues G; Tillery GW; Goldstein R; Klintmalm G; Stone MJ Clin Cancer Res; 1996 Mar; 2(3):531-9. PubMed ID: 9816200 [TBL] [Abstract][Full Text] [Related]
13. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance. Wang C; Wei X; Shao G Med Sci Monit; 2021 Feb; 27():e927727. PubMed ID: 33524008 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction. Manov I; Pollak Y; Broneshter R; Iancu TC FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999 [TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of Manuka honey on human colon cancer HCT-116 and LoVo cell growth. Part 1: the suppression of cell proliferation, promotion of apoptosis and arrest of the cell cycle. Afrin S; Giampieri F; Gasparrini M; Forbes-Hernández TY; Cianciosi D; Reboredo-Rodriguez P; Amici A; Quiles JL; Battino M Food Funct; 2018 Apr; 9(4):2145-2157. PubMed ID: 29645049 [TBL] [Abstract][Full Text] [Related]
16. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation. Liu H; Chen W; Liang C; Chen BW; Zhi X; Zhang S; Zheng X; Bai X; Liang T Cancer Lett; 2015 Jun; 361(2):218-25. PubMed ID: 25749422 [TBL] [Abstract][Full Text] [Related]
17. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling. Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line RLN-10 in combination with 2-deoxy-D-glucose. Takemura A; Che XF; Tabuchi T; Moriya S; Miyazawa K; Tomoda A Oncol Rep; 2012 Feb; 27(2):347-55. PubMed ID: 22076586 [TBL] [Abstract][Full Text] [Related]
19. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430 [TBL] [Abstract][Full Text] [Related]
20. Extracellular Ca(2+) Selectively Enhances Adriamycin-induced Cell Death in Human Hepatoma Cells. Huang X; Xu Y; Liu Y; Xie H; Wang J; Wu Z Curr Cancer Drug Targets; 2015; 15(6):481-92. PubMed ID: 26282547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]